Abstract
Pharmaceutical direct-to-consumer advertising (DTCA) has grown exponentially and is suggested to increase perceived medication needs and patient drug requests. However, its impact on healthcare consumer safety is not well-understood. This effort sought to examine DTCA healthcare consumer effects and their public health and practical implications. During spring 2008, 2767 individuals were asked, through public intercept interviews, about pharmaceutical DTCA: recalled products, exposure frequency, exposure medium, and impact on a range of health-related behaviors and beliefs. Consumers report inundation with DTCA, with 8 of 10 respondents indicating exposure to messaging within the past 30 days. Television was the medium with the most noted impressions; direct mail, the least (although still >35%). Most impressions reported were for Viagra and Claritin. One of four participants reported cognitive or behavioral changes as a result of viewing DTCA: advertisements prompted people to believe they had an illness/condition, to seek more information, to schedule provider visits, and to ask providers about symptoms or medications during regular visits. Moreover, almost 1 in 5 reported an increased willingness to share their prescription medication with others if they saw it in DTCA, indicating that DTCA exposure may increase this risky behavior. DTCA are nearly ubiquitous yet consumers remained attuned to the message content. The effects of DTCA are complex and range from beneficial (e.g., information-seeking) to detrimental (e.g. medication-sharing). Interestingly, participants do not readily differentiate prescription versus over-the-counter DTCA. Increased attention to understanding DTCA appears worthwhile, perhaps targeting provider awareness of message effect, further regulation and modification of DTCA messaging, and enhancing DTCA media literacy as a component of health literacy. Human factors professionals have the right toolset to play an active role in these efforts.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have